- Home
- XOMA vs KTWO Comparison
XOMA vs KTWO Comparison
Compare XOMA & KTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$41.56
Company Overview
Basic Information| Metric | XOMA | KTWO |
|---|---|---|
| Founded | 1981 | 2025 |
| Country | United States | Cayman Islands |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.6M | 431.2M |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | XOMA | KTWO |
|---|---|---|
| Price | $41.56 | $10.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 272.3K | 69.8K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.59 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.29 | $9.84 |
| 52 Week High | $42.81 | $10.01 |
Technical Indicators
Market Signals| Indicator | XOMA | KTWO |
|---|---|---|
| Relative Strength Index (RSI) | 71.23 | 64.98 |
| Support Level | $24.38 | N/A |
| Resistance Level | N/A | $10.00 |
| Average True Range (ATR) | 1.58 | 0.04 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 76.97 | 81.48 |
Price Performance
Historical Comparison XOMA
KTWO
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.